Sort
59,101 grants matching “hypertension”
Initiating Factors for Hypertension
$685,827Steven C. Hunt · University Of Utah · R01 · FY2011 · HL
Telecom Technology to Improve Adherence to Medication
$685,738Boston Medical Center · R01 · FY2004 · AG
Quantifying cardiac structure and function to define the progression to hear failure in African Americans
$685,735Amil M Shah · Brigham And Women'S Hospital · R01 · FY2021 · HL
Network Medicine and Systems Pharmacology to Advance Precision Medicine in Combined Pulmonary Hypertension
$685,723Evan L Brittain · Vanderbilt University Medical Center · R01 · FY2024 · HL
FEASible: Sensing Factors of Environment, Activity, and Sleep to Validate Metabolic Health Burden Among Latina Women
$685,718Andreana Petrova Haley · University Of Texas At Austin · R01 · FY2025 · HL
Renin cell identity and blood pressure homeostasis
$685,695Maria L Sequeira Lopez · University Of Virginia · R01 · FY2020 · HL
Structural Studies of Ion Channel Assembly and Signaling Complexes
$685,689Daniel L Minor · University Of California, San Francisco · R01 · FY2024 · DC
Low-level Arsenic Exposure and Cardiovascular Disease in Multi-Ethnic Adults (MESA As)
$685,658Ana Navas-Acien · Columbia University Health Sciences · R01 · FY2018 · ES
Tissue transglutaminase as a therapeutic target for arterial stiffening and hypertension in obesity
$685,654Luis A Martinez-Lemus · University Of Missouri-Columbia · R01 · FY2025 · HL
EXpanding Technology-Enabled, Nurse-Delivered Chronic Disease Care (EXTEND)
$685,646Ryan Jeffrey Shaw · Duke University · R01 · FY2022 · NR
Caveolar Defects Underlie the Genetic Origins of PAH
$685,585James E Loyd · Vanderbilt University · R01 · FY2012 · HL
Links between Cardiovascular disease, Lung disease, and Obstructive sleep apnea in HIV: Understanding complex patients
$685,518Heidi M. Crane · University Of Washington · R01 · FY2023 · HL
REHAB-PH Trial: Repurposing a Histamine Antagonist to Benefit Patients with Pulmonary Hypertension
$685,472Peter J Leary · University Of Washington · R61 · FY2018 · HL
Polygenic Risk of Disease in Populations of Diverse Ancestry
$685,446Iftikhar J Kullo · Mayo Clinic Rochester · U01 · FY2022 · HG
Polygenic Risk of Disease in Populations of Diverse Ancestry
$685,446Iftikhar J Kullo · Mayo Clinic Rochester · U01 · FY2021 · HG
iSIPsmarter: An RCT to evaluate the efficacy, reach, and engagement of a technology-based behavioral and health literacy intervention to reduce sugary beverages among rural Appalachian adults
$685,337Jamie Zoellner · University Of Virginia · R01 · FY2022 · MD
PBK: A novel mediator of VSMC proliferation and vascular remodeling in PAH
$685,300David J Fulton · Augusta University · R01 · FY2021 · HL
PBK: A novel mediator of VSMC proliferation and vascular remodeling in PAH
$685,300David J Fulton · Augusta University · R01 · FY2022 · HL
Circadian origins of vascular disease in obesity
$685,300David W Stepp · Augusta University · R01 · FY2022 · HL
Circadian origins of vascular disease in obesity
$685,300David W Stepp · Augusta University · R01 · FY2021 · HL
PBK: A novel mediator of VSMC proliferation and vascular remodeling in PAH
$685,300David J Fulton · Augusta University · R01 · FY2023 · HL
Genetic Determinants of Visceral Adiposity
$685,217Yongmei Liu · Wake Forest University Health Sciences · R01 · FY2010 · AG
Development of RNAi based sFLT1-targeting therapeutics for treatment of Preeclampsia
$685,210Anastasia Khvorova · Univ Of Massachusetts Med Sch Worcester · R01 · FY2017 · HD
Optimal Oxygenation in Neonatal Lung Injury
$685,208Satyanarayana Lakshminrusimha · University Of California At Davis · R01 · FY2024 · HD
HYPERGEN DATA COORDINATING CENTER
$685,189Washington University · U01 · FY2000 · HL